Close

Tech Finds Diabetic Retinopathy And Macular Edema In Taiwan

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back

Related stories

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

UK Life Sciences Sector Plan Eases Startup Regulations

How the UK Life Sciences Sector Plan Reduces Regulatory...

The Point-of-Care AI-DR is the first artificial intelligence (AI)-assisted system that can be integrated into handheld and desktop fundus cameras frequently used in clinics and hospitals to detect diabetic retinopathy (DR) and diabetic macular edema (DME). It has been developed by Taiwan’s Industrial Technology Research Institute.

Point-of-Care AI-DR detects DR and DME in 5 to 10 seconds and evaluates immediately the quality of the image prior to diagnosis to avoid AI misunderstandings. Based on the fundus images, it identifies lesions and evaluates the corresponding severity levels.

Additionally, it can detect 14 additional frequent ocular fundus anomalies, including conditions linked to the retina, blood vessel alterations, and illnesses of the optic nerve. Moreover, half of diabetics will get DR, and one in 15 will acquire DME, as per the National Eye Institute. Point-of-Care AI-DR enhances diabetes health monitoring and treatment by recognising defects and intensity stages of DR and DME, which lowers the chances of loss of vision or blindness brought on by diabetic eye problems.

Point-of-Care AI-DR combines the knowledge of ophthalmologists with AI analysis to combine human and artificial intelligence. To increase the effectiveness of the overall interpretation, it employs complementary medical AI models to carry out individual diagnostic tasks, including classifying and identifying symptoms, Dr. Pang-An Ting, ITRI’s general director of Information and Communications Research Laboratories, remarked.

Latest stories

Related stories

Life Sciences Sector Plan Sets UK on Global Growth Track

Main Article: UK Life Sciences Sector Plan Sets Sights...

UK Government Launches Ambitious Life Sciences Sector Plan

Government Unveils Life Sciences Roadmap for Growth and Innovation London,...

Highly Customized Treatments to Offer Specialized Care to UK

The Human Medicines Regulations 2025, which came into force...

UK Life Sciences Sector Plan Eases Startup Regulations

How the UK Life Sciences Sector Plan Reduces Regulatory...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from any location or device.

Media Packs

Expand Your Reach With Our Customized Solutions Empowering Your Campaigns To Maximize Your Reach & Drive Real Results!

– Access the Media Pack Now

– Book a Conference Call

– Leave Message for Us to Get Back